InvestorsHub Logo
Followers 17
Posts 544
Boards Moderated 0
Alias Born 02/06/2010

Re: None

Saturday, 10/17/2020 10:37:55 AM

Saturday, October 17, 2020 10:37:55 AM

Post# of 113917
At UGA the lead molecule developed by SBFM is being studied to see how effective it is in attacking PLpro, a papain like protease, which is a main component of viruses, SARS COVID-2 the causative agent of COVID 19. PLpro is responsible for the replication of the virus molecule. The test involves three stages: in vitro study, cell culture studies and mice studies. If proven successful in neutralizing PL pro, UGA will submit its findings to the FDA to begin human trials for the development of a vaccine.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News